Further supporting the role of the TDLN in CIT, Alsaid et al.54 demonstrated increased uptake of [89Zr]IAB42M1-14, an anti-CD8+ minibody, in the TDLNs of tumor-bearing mice during CIT. Here, CD8A is linked to neoplasm.